IMDELLTRA (tarlatamab-dlle) for injection
IMDELLTRA is a prescription medicine used to treat extensive-stage small cell lung cancer (ES-SCLC) called a T-cell engager. FDA approved tarlatamab-dlle (brand name IMDELLTRA) is not (yet) registered or available in India but on request Indian patient can buy IMDELLTRA at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
IMDELLTRA (tarlatamab-dlle) for injection
Tarlatamab-dlle is used for treatment of advanced small cell lung cancer (SCLC) that has progressed on or after other treatments. Tarlatamab-dlle is in a class of medications called bispecific T-cell engager antibodies. It works by slowing or stopping the growth of cancer cells in your body.
IMDELLTRA is a prescription medicine used to treat adults with extensive stage small cell lung cancer (ES-SCLC), which is cancer that has spread throughout the lung or to other parts of the body, and who have received treatment with chemotherapy that contains platinum, and it did not work or is no longer working.
Tarlatamab-dlle is used for treatment of advanced small cell lung cancer (SCLC) that has progressed on or after other treatments. Tarlatamab-dlle is in a class of medications called bispecific T-cell engager antibodies. It works by slowing or stopping the growth of cancer cells in your body.
IMDELLTRA (tarlatamab-dlle) for injection, for intravenous use Initial U.S. Approval: 2024
—————-
Current Indication: Treat small cell lung cancer (ES-SCLC) called a T-cell engager
—————-
Marketed By: Amgen Inc
—————-
Approval Date: : 2024
—————-
Active ingredients: tarlatamab-dlle
—————-
Inactive ingredients: glutamic acid, polysorbate 80, sucrose, and sodium hydroxide.
Inactive ingredients of IV Solution Stabilizer: citric acid monohydrate, lysine hydrochloride, polysorbate 80, sodium
hydroxide and water for Injection
—————-
For injection: 1 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution.
For injection: 10 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution.
Find Reference Updates
- For IMDELLTRA (tarlatamab-dlle) for injection And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- Imdelltra (tarlatamab-dlle)
- Amgen's Imdelltra wins Korean nod for tough-to-treat lung cancer
- IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER
- FDA grants accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer
- FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ IMDELLTRA (tarlatamab-dlle) for injection ”. Confirmation of the order for IMDELLTRA (tarlatamab-dlle) for injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for IMDELLTRA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Get Access to Treatment – IMDELLTRA
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
IMDELLTRA Sourcing & Delivery
Alleviare India specializes in sourcing and supplying IMDELLTRA, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of IMDELLTRA in India.
How much does IMDELLTRA cost in the India?
Kindly reach out to us for IMDELLTRA (tarlatamab-dlle) for injection price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import IMDELLTRA to India?
To import tarlatamab-dlle – IMDELLTRA, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is IMDELLTRA available in India?
IMDELLTRA – tarlatamab-dlle is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of IMDELLTRA (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for IMDELLTRA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is tarlatamab-dlle available in India?
Yes, FDA approved tarlatamab-dlle (brand name IMDELLTRA) is not (yet) registered or available in India but on request Indian patient can buy IMDELLTRA at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand IMDELLTRA (tarlatamab-dlle) for injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
